We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

Independent Non-Executive Director of Critical Mineral Resources Russell Thomson Buys More Stock

Potential Critical Mineral Resources PLC (LON:CMRS) shareholders may wish to note that the Independent Non-Executive Director, Russell Thomson, recently bought UK£375k worth of stock, paying UK£0.038 for each share. Although the purchase is not a big one, by either a percentage standpoint or absolute …

EODHD | 01 February 2024

If EPS Growth Is Important To You, Whitehaven Coal (ASX:WHC) Presents An Opportunity

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors. Unfortunately, these high risk investments …

EODHD | 31 January 2024

Here's Why We Think Medibank Private (ASX:MPL) Is Well Worth Watching

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Unfortunately, these high risk investments often have little probability of ever paying off, and many investors pay a price …

EODHD | 31 January 2024

C.H. Robinson Worldwide (CHRW) Q4 Earnings and Revenues Lag Estimates

C.H. Robinson Worldwide (CHRW) came out with quarterly earnings of $0.50 per share, missing the Zacks Consensus Estimate of $0.80 per share. This compares to earnings of $1.03 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …

EODHD | 31 January 2024

Northern Star Resources Limited's (ASX:NST) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Most readers would already be aware that Northern Star Resources' (ASX:NST) stock increased significantly by 14% over the past three months. We wonder if and what role the company's financials play in that price change as a company's long-term fundamentals usually dictate market outcomes. …

EODHD | 31 January 2024

Enbridge Provides Notice of Series 7 Preferred Shares Conversion Right and Announces Reset Dividend Rates

CALGARY, AB, Jan. 31, 2024 /CNW/ - Enbridge Inc. (TSX: ENB) (NYSE: ENB) (Enbridge or the Company) announced today that it does not intend to exercise its right to redeem its currently outstanding Cumulative Redeemable Preference Shares, Series 7 (Series 7 Shares) (TSX: ENB.PR.J) …

EODHD | 31 January 2024

Enbridge Provides Notice of Series 5 Preferred Shares Conversion Right and Announces Reset Dividend Rates

CALGARY, AB, Jan. 31, 2024 /PRNewswire/ - Enbridge Inc. (TSX: ENB) (NYSE: ENB) (Enbridge or the Company) announced today that it does not intend to exercise its right to redeem its currently outstanding Cumulative Redeemable Preference Shares, Series 5 (Series 5 Shares) (TSX: ENB.PF.V) …

EODHD | 31 January 2024

Enbridge Provides Notice of Series P Preferred Shares Conversion Right and Announces Reset Dividend Rates

CALGARY, AB, Jan. 31, 2024 /CNW/ - Enbridge Inc. (TSX: ENB) (NYSE: ENB) (Enbridge or the Company) announced today that it does not intend to exercise its right to redeem its currently outstanding Cumulative Redeemable Preference Shares, Series P (Series P Shares) (TSX: ENB.PR.P) …

EODHD | 31 January 2024

PrairieSky Royalty Announces Conference Call for 2023 Fourth Quarter and Year-End Results

PrairieSky Royalty Ltd. CALGARY, Alberta, Jan. 31, 2024 (GLOBE NEWSWIRE) -- PrairieSky will release its 2023 annual and fourth quarter results on Monday, February 12, 2024 after markets close. The news release detailing PrairieSky’s 2023 fourth quarter and year-end results will provide operating and …

EODHD | 31 January 2024

Galapagos completes transaction to transfer Jyseleca® business to Alfasigma

Galapagos NV Mechelen, Belgium; 31 January 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced the successful completion of the transaction to transfer its Jyseleca® (filgotinib) business to Alfasigma S.p.A. As previously announced, the transfer includes the entire Jyseleca® business, including the …

EODHD | 31 January 2024
Support

Hi! How can we help you today?

Loading…